COMPARISON OF NUCLEOTIDE AND DEDUCED AMINO-ACID-SEQUENCE OF THE 5' NONCODING REGION AND STRUCTURAL PROTEIN GENES OF THE WILD-TYPE JAPANESE ENCEPHALITIS-VIRUS STRAIN-SA14 AND ITS ATTENUATED VACCINE DERIVATIVES

被引:71
作者
NI, HL
BURNS, NJ
CHANG, GJJ
ZHANG, MJ
WILLS, MR
TRENT, DW
SANDERS, PG
BARRETT, ADT
机构
[1] CTR DIS CONTR & PREVENT, NATL CTR INFECT DIS, DIV VECTOR BORNE INFECT DIS, FT COLLINS, CO 80522 USA
[2] ADDENBROOKES HOSP, DEPT MED, CAMBRIDGE CB2 2QQ, CAMBS, ENGLAND
[3] UNIV SURREY, SCH BIOL SCI, MOLEC MICROBIOL RES GRP, GUILDFORD GU2 5XH, SURREY, ENGLAND
关键词
D O I
10.1099/0022-1317-75-6-1505
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nucleotide sequences of the 5' non-coding region and the structural protein genes of the live, attenuated Japanese encephalitis vaccine virus strains SA14-2-8 and SA14-5-3 and the wild-type parental strain SA14/USA were determined. SA14-2-8 differed from SA14/USA by 13 nucleotides and eight amino acids whereas SA14-5-3 differed from SA14/USA by 15 nucleotides and eight amino acids. A comparison of the 5' noncoding region and amino acid sequences of the structural proteins of these two attenuated vaccine strains and of vaccine strains SA14-14-2/PHK and SA14-14-2/PDK with three sequences of their wild-type parent SA14 virus was performed. This revealed only two common amino acid substitutions at positions 138 and 176 in the envelope (E) protein. The substitution at E138 was predicted to cause a change in the secondary structure of the E protein. These two amino acid substitutions in the E protein may contribute to attenuation of the Japanese encephalitis vaccine viruses.
引用
收藏
页码:1505 / 1510
页数:6
相关论文
共 32 条
  • [1] IDENTIFICATION OF MUTATIONS THAT OCCURRED ON THE GENOME OF JAPANESE ENCEPHALITIS-VIRUS DURING THE ATTENUATION PROCESS
    AIHARA, S
    CHUNMING, R
    YONGXIN, Y
    LEE, T
    WATANABE, K
    KOMIYA, T
    SUMIYOSHI, H
    HASHIMOTO, H
    NOMOTO, A
    [J]. VIRUS GENES, 1991, 5 (02) : 95 - 109
  • [2] AO J, 1983, CHIN J MICROBIOL IMM, V3, P245
  • [3] Barrett A. D. T., 1991, Vaccines 91. Modern approaches to new vaccines including prevention of AIDS., P259
  • [4] Brinton MA., 1986, TOGAVIRIDAE FLAVIVIR, P327
  • [5] NUCLEOTIDE CHANGES RESPONSIBLE FOR LOSS OF NEUROINVASIVENESS IN JAPANESE ENCEPHALITIS-VIRUS NEUTRALIZATION-RESISTANT MUTANTS
    CECILIA, D
    GOULD, EA
    [J]. VIROLOGY, 1991, 181 (01) : 70 - 77
  • [6] FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATION
    CHAMBERS, TJ
    HAHN, CS
    GALLER, R
    RICE, CM
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 1990, 44 : 649 - 688
  • [7] CHEN BC, 1974, ACTA MICROBIOL SIN, V14, P176
  • [8] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [9] JAPANESE ENCEPHALITIS-VIRUS LIVE-ATTENUATED VACCINE, CHINESE STRAIN SA14-14-2 - ADAPTATION TO PRIMARY CANINE KIDNEY-CELL CULTURES AND PREPARATION OF A VACCINE FOR HUMAN USE
    ECKELS, KH
    YONGXIN, Y
    DUBOIS, DR
    MARCHETTE, NJ
    TRENT, DW
    JOHNSON, AJ
    [J]. VACCINE, 1988, 6 (06) : 513 - 518
  • [10] FLAVIVIRUS INFECTION ENHANCEMENT IN MACROPHAGES - RADIOACTIVE AND BIOLOGICAL STUDIES ON THE EFFECT OF ANTIBODY ON VIRAL FATE
    GOLLINS, SW
    PORTERFIELD, JS
    [J]. JOURNAL OF GENERAL VIROLOGY, 1984, 65 (AUG) : 1261 - 1272